Evaluating fibroblast growth factor receptor (FGFR) pathway mRNA expression and protein activation in cholangiocarcinoma tumors
L Stein, JW Reeser, MR Wing, E Samorodnitsky, A Paruchuri, A Smith, et al.
π Journal of Clinical and Translational Science
π
2025
FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer
L Stein, K Murugesan, JW Reeser, Z Risch, MR Wing, A Paruchuri, et al.
π NPJ Precision Oncology
π
2024
π 5 citations
Analytic validation of an FGFR-focused cell-free DNA liquid biopsy assay (FGFR-Dx)
JW Reeser, MR Wing, E Samorodnitsky, T Dao, A Smith, L Stein, et al.
π medRxiv
π
2024
π 1 citation
A phase II telemedicine study of pemigatinib in adult patients with unresectable or metastatic pancreas cancer with FGFR2 gene fusions or other FGFR genetic alterations
Z Risch, M Wing, J Reeser, L Stein, T Dao, A Smith, E Samorodnitsky, et al.
π Journal of Clinical Oncology
π
2024
A systematic approach for detection of tumor genomic alterations which alter the immune microenvironment
R Vella, EL Hoskins, JW Reeser, MR Wing, E Samorodnitsky, A Paruchuri, et al.
π Cancer Research
π
2023
Clinical impact of FGFR inhibitors on FGFR2 positive pancreatic cancer
L Stein, JW Reeser, MR Wing, K Murugesan, A Paruchuri, Z Risch, et al.
π Cancer Research
π
2023
π 3 citations
Pan-cancer landscape of programmed death ligand-1 and programmed death ligand-2 structural variations
EL Hoskins, E Samorodnitsky, MR Wing, JW Reeser, JF Hopkins, A Paruchuri, et al.
π JCO Precision Oncology
π
2023
π 8 citations
Identification of cancer hotspot residues and driver mutations using machine learning
M Pandey, P Anoosha, D Yesudhas, MM Gromiha
π Machine Learning in Bioinformatics of Protein Sequences
π
2023
π 3 citations
Identification of potential driver mutations in glioblastoma using machine learning
M Pandey, P Anoosha, D Yesudhas, MM Gromiha
π Briefings in Bioinformatics
π
2022
π 22 citations
Pan-cancer landscape and impact of PD-L1 and PD-L2 structural variation
EL Hoskins, E Samorodnitsky, MR Wing, JW Reeser, J Hopkins, A Paruchuri, et al.
π Cancer Research
π
2022
Ppar-responsive elements enriched with alu repeats may contribute to distinctive pparΞ³βdnmt1 interactions in the genome
A Sharma, F Tobar-Tosse, T Chand Dakal, H Liu, A Biswas, A Menon, et al.
π Cancers
π
2021
π 4 citations
Genomic and transcriptomic characterization of relapsed SCLC through rapid research autopsy
HZ Chen, R Bonneville, A Paruchuri, JW Reeser, MR Wing, et al.
π JTO Clinical and Research Reports
π
2021
π 20 citations
Characterization of clonal evolution in microsatellite unstable metastatic cancers through multiregional tumor sequencing
R Bonneville, A Paruchuri, MR Wing, MA Krook, JW Reeser, HZ Chen, et al.
π Molecular Cancer Research
π
2021
π 7 citations
Research autopsy demonstrates polyclonal acquired resistance in a patient with metastatic GI stromal tumor
A Paruchuri, HZ Chen, R Bonneville, JW Reeser, MR Wing, MA Krook, et al.
π JCO Precision Oncology
π
2020
π 2 citations
Quantitative structureβactivity relationship in ligand-based drug design: Concepts and applications
V Kanakaveti, P Anoosha, R Sakthivel, SK Rayala, MM Gromiha
π Protein Interactions: Computational Methods, Analysis and Applications
π
2020
π 8 citations